0

531015

VENMAX

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VENMAX DRUGS AND PHARMACEUTICA Share Price Today

Investment Returns

Over 1 Month -17.35% Over 3 Months -21.50% Over 6 Months -28.05% Over 1 Year -25.59%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VENMAX DRUGS AND PHARMACEUTICA fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 23.20
  • P/E Ratio (TTM) 95.24
  • Beta 0.46
  • Book Value / share 12.18
  • Return on equity 0.00%
  • EPS (TTM) 0.21
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.11
info icon alternate text

VENMAX DRUGS AND PHARMACEUTICA Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3.94
Operating Expense 3.93
Net Profit 0.11
Net Profit Margin (%) 2.79
Earnings Per Share (EPS) 0.21
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 1.55
Operating Expense 1.58
Net Profit 0.03
Net Profit Margin (%) 1.93
Earnings Per Share (EPS) 0.05
EBITDA 0.04
Effective Tax Rate (%) 25.00
Particulars SEP 2025 (Values in Cr)
Revenue 1.32
Operating Expense 1.27
Net Profit 0.02
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.05
EBITDA 0.05
Effective Tax Rate (%) 40.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.21
Operating Expense 1.17
Net Profit 0.04
Net Profit Margin (%) 3.30
Earnings Per Share (EPS) 0.07
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.33
Operating Expense 0.58
Net Profit 0.78
Net Profit Margin (%) 236.36
Earnings Per Share (EPS) 1.49
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 8.02
Operating Expense 7.91
Net Profit 0.25
Net Profit Margin (%) 3.11
Earnings Per Share (EPS) 0.21
EBITDA 0.28
Effective Tax Rate (%) 10.71
Particulars MAR 2025 (Values in Cr)
Revenue 0.81
Operating Expense 1.87
Net Profit -0.01
Net Profit Margin (%) -1.23
Earnings Per Share (EPS) -0.02
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.09
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 0.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.43
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit 1.85
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.52
EBITDA 1.86
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -1.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.11
EBITDA Margin 14.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share -1.24
ROE % 1.15
ROCE % 1.43
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.36
ROE % 4.10
ROCE % 3.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.79
ROE % 116.35
ROCE % 63.14
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.32
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -88.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 5.16
Total Liabilities 5.16
Total Equity 4.41
Share Outstanding 0
Price to Book Ratio -22.63
Return on Assets (%) -0.20
Return on Capital (%) -0.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.08
Total Liabilities 0.08
Total Equity -0.65
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 79.23
Return on Capital (%) -21.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.71
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 106.71
Return on Capital (%) -62.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.94
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 864.37
Return on Capital (%) -312.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 0.30
Total Liabilities 0.30
Total Equity -2.78
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -52.82
Return on Capital (%) 35.53
Particulars MAR 2025 (Values in Cr)
Net Income -0.01
Cash from Operations -2.29
Cash from Investing 0.00
Cash from Financing 4.77
Net change in Cash 2.47
Free Cash Flow -2.29
Particulars MAR 2024 (Values in Cr)
Net Income 0.08
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.22
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 1.84
Cash from Operations 1.90
Cash from Investing 0.00
Cash from Financing -1.98
Net change in Cash -0.07
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.16
Cash from Operations 0.26
Cash from Investing 0.00
Cash from Financing -0.18
Net change in Cash 0.07
Free Cash Flow 0.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD. 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2120.70 37.34 15.84 35925.94 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTAJAN HEALTH LTD 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.10 47.26 4.02 4646.32 118.35 462.70

VENMAX DRUGS AND PHARMACEUTICA shareholding pattern

Holding
86.2%
13.79%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VENMAX DRUGS AND PHARMACEUTICA Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
20.00 0.25 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 20.30
  • 26 Days 22.50
  • 10 Days 21.00
  • 50 Days 23.50
  • 12 Days 21.20
  • 100 Days 24.50
  • 20 Days 22.00
  • 200 Days 24.50
20.43 PIVOT
First Support 19.47 First Resistance 20.92 Second Support 18.98 Second Resistance 21.88 Third Support 18.02 Third Resistance 22.37
RSI 36.30 ADX 16.59 MACD -1.21 Williams % R -90.43 Commodity Channel Index (CCI) -101.63
Date 2026-06-12 Week 2273.00 Same Day 1296.00 Month 1982.00
1 Year 0.46 3 Year 0.30
Over 1 Month
-17.35% down
Over 1 Year
-25.59% down
Over 3 Months
-21.50% down
Over 3 Years
0.00% down
Over 6 Months
-28.05% down
Over 5 Years
0.00% down

VENMAX DRUGS AND PHARMACEUTICA Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

Venmax Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 20.00 as on Jun 12 2026 03:24 PM.

What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Venmax Drugs & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 23.20 as on Jun 12 2026 03:24 PM.

What is the 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 36.96 and ₹ 19.01.

What is 1 year return for Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -25.59%.

What is the P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 03:24 PM the price-to-earnings (PE) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 95.24.

What is the PB ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 12 2026 03:24 PM, the price-to-book (PB) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 12.18.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Venmax Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Venmax Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Venmax Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|